Tissue factor pathway inhibitor (or TFPI) is a single-chain polypeptide which can reversibly inhibit Factor Xa (Xa). While Xa is inhibited, the Xa-TFPI complex can subsequently also inhibit the FVIIa-tissue factor complex. TFPI contributes significantly to the inhibition of Xa in vivo, despite being present at concentrations of only 2.5 nM.
The gene for TFPI is located on chromosome 2q31-q32.1, and has nine exons which span 70 kb. The gene has not been completely sequenced yet. A similar gene, termed TFPI2, has been identified on chromosome 7q22; in addition to TFPI activity, its product also has retinal pigment epithelial cell growth-promoting properties.
^Broze, G J; Warren L A; Novotny W F; Higuchi D A; Girard J J; Miletich J P (Feb 1988). "The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action". Blood (UNITED STATES) 71 (2): 335–43. ISSN0006-4971. PMID3422166.
Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP (2002). "Structure and biology of tissue factor pathway inhibitor.". Thromb. Haemost.86 (4): 959–72. PMID11686353.
Witt I (2002). "[Tissue factor pathway inhibitor: biochemistry, molecular biology, physiology and physiopathology]". Hamostaseologie22 (2): 30–5. doi:10.1267/Hamo02020071. PMID12193974.
Lwaleed BA, Bass PS (2006). "Tissue factor pathway inhibitor: structure, biology and involvement in disease.". J. Pathol.208 (3): 327–39. doi:10.1002/path.1871. PMID16261634.
Van der Logt CP, Kluck PM, Wiegant J et al. (1992). "Refined regional assignment of the human tissue factor pathway inhibitor (TFPI) gene to chromosome band 2q32 by non-isotopic in situ hybridization.". Hum. Genet.89 (5): 577–8. doi:10.1007/bf00219189. PMID1353057.
Higuchi DA, Wun TC, Likert KM, Broze GJ (1992). "The effect of leukocyte elastase on tissue factor pathway inhibitor.". Blood79 (7): 1712–9. PMID1558967.
van der Logt CP, Reitsma PH, Bertina RM (1991). "Intron-exon organization of the human gene coding for the lipoprotein-associated coagulation inhibitor: the factor Xa dependent inhibitor of the extrinsic pathway of coagulation.". Biochemistry30 (6): 1571–7. doi:10.1021/bi00220a018. PMID1993173.
Girard TJ, Eddy R, Wesselschmidt RL et al. (1991). "Structure of the human lipoprotein-associated coagulation inhibitor gene. Intro/exon gene organization and localization of the gene to chromosome 2.". J. Biol. Chem.266 (8): 5036–41. PMID2002045.
Wun TC, Kretzmer KK, Girard TJ et al. (1988). "Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.". J. Biol. Chem.263 (13): 6001–4. PMID2452157.
Novotny WF, Girard TJ, Miletich JP, Broze GJ (1989). "Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.". J. Biol. Chem.264 (31): 18832–7. PMID2553722.
Girard TJ, Warren LA, Novotny WF et al. (1989). "Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein.". Thromb. Res.55 (1): 37–50. doi:10.1016/0049-3848(89)90454-4. PMID2781520.
Girard TJ, Warren LA, Novotny WF et al. (1989). "Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor.". Nature338 (6215): 518–20. doi:10.1038/338518a0. PMID2927510.
Broze GJ, Miletich JP (1987). "Characterization of the inhibition of tissue factor in serum.". Blood69 (1): 150–5. PMID3024756.
Broze GJ, Warren LA, Novotny WF et al. (1988). "The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.". Blood71 (2): 335–43. PMID3422166.
Rao LV, Rapaport SI (1987). "Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation.". Blood69 (2): 645–51. PMID3492226.
Stubbs MT, Huber R, Bode W (1996). "Crystal structures of factor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of factor Xa and selectivity against thrombin.". FEBS Lett.375 (1-2): 103–7. doi:10.1016/0014-5793(95)01190-P. PMID7498454.